| Literature DB >> 29515254 |
Najla El-Hachem1, Nadia Habel1, Tanesha Naiken1, Hanene Bzioueche1, Yann Cheli1, Guillaume E Beranger1, Emilie Jaune1, Florian Rouaud1, Nicolas Nottet2, Frédéric Reinier1, Céline Gaudel1, Pascale Colosetti3, Corine Bertolotto1, Robert Ballotti4.
Abstract
HACE1 is an E3 ubiquitin ligase described as a tumour suppressor because HACE1-knockout mice develop multi-organ, late-onset cancers and because HACE1 expression is lost in several neoplasms, such as Wilms' tumours and colorectal cancer. However, a search of public databases indicated that HACE1 expression is maintained in melanomas. We demonstrated that HACE1 promoted melanoma cell migration and adhesion in vitro and was required for mouse lung colonisation by melanoma cells in vivo. Transcriptomic analysis of HACE1-depleted melanoma cells revealed an inhibition of ITGAV and ITGB1 as well changes in other genes involved in cell migration. We revealed that HACE1 promoted the K27 ubiquitination of fibronectin and regulated its secretion. Secreted fibronectin regulated ITGAV and ITGB1 expression, as well as melanoma cell adhesion and migration. Our findings disclose a novel molecular cascade involved in the regulation of fibronectin secretion, integrin expression and melanoma cell adhesion. By controlling this cascade, HACE1 displays pro-tumoural properties and is an important regulator of melanoma cell invasive properties.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29515254 PMCID: PMC6219503 DOI: 10.1038/s41418-018-0090-y
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828